Abstract
Copy number variations (CNVs) are rare genomic deletions and duplications that can affect brain and behaviour. Previous reports of CNV pleiotropy imply that they converge on shared mechanisms at some level of pathway cascades, from genes to large-scale neural circuits to the phenome. However, existing studies have primarily examined single CNV loci in small clinical cohorts. It remains unknown, for example, how distinct CNVs escalate vulnerability for the same developmental and psychiatric disorders. Here we quantitatively dissect the associations between brain organization and behavioural differentiation across 8 key CNVs. In 534 CNV carriers, we explored CNV-specific brain morphology patterns. CNVs were characteristic of disparate morphological changes involving multiple large-scale networks. We extensively annotated these CNV-associated patterns with ~1,000 lifestyle indicators through the UK Biobank resource. The resulting phenotypic profiles largely overlap and have body-wide implications, including the cardiovascular, endocrine, skeletal and nervous systems. Our population-level investigation established brain structural divergences and phenotypical convergences of CNVs, with direct relevance to major brain disorders.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The majority of 16p11.2 data are publicly available (https://www.sfari.org/). For the 22q11.2 sample, raw data are available upon request from the PI (C.E.B., cbearden@mednet.ucla.edu). All derived measures used in this study are available upon request (S.J., sebastien.jacquemont@umontreal.ca). The rest of the CNV carriers’ data cannot be shared as participants did not provide consent. All data from UK Biobank are available to other investigators online (ukbiobank.ac.uk). The Schaefer-Yeo atlas is accessible online (https://github.com/ThomasYeoLab/CBIG/tree/master/stable_projects/brain_parcellation/Schaefer2018_LocalGlobal). Source data are provided with this paper.
Code availability
The processing scripts and custom analysis software used in this work are available in a publicly accessible GitHub repository along with examples of key visualizations in the paper: https://github.com/dblabs-mcgill-mila/CNV-convergence.
References
Freeman, J. L. et al. Copy number variation: new insights in genome diversity. Genome Res. 16, 949–961 (2006).
Conrad, D. F. et al. Origins and functional impact of copy number variation in the human genome. Nature 464, 704–712 (2010).
Auwerx, C. et al. The individual and global impact of copy-number variants on complex human traits. Am. J. Hum. Genet. https://doi.org/10.1016/j.ajhg.2022.02.010 (2022).
Jacquemont, S. et al. Genes to mental health (G2MH): a framework to map the combined effects of rare and common variants on dimensions of cognition and psychopathology. Am. J. Psychiatry 179, 189–203 (2021).
Rutkowski, T. P. et al. Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders. J. Neurosci. Res. 95, 1144–1160 (2017).
Lauer, S. & Gresham, D. An evolving view of copy number variants. Curr. Genet. 65, 1287–1295 (2019).
Huguet, G. et al. Genome-wide analysis of gene dosage in 24,092 individuals estimates that 10,000 genes modulate cognitive ability. Mol. Psychiatry 26, 2663–2676 (2021).
Moberg, P. J. et al. Neurocognitive functioning in patients with 22q11.2 deletion syndrome: a meta-analytic review. Behav. Genet. 48, 259–270 (2018).
Silva, A. I. et al. Neuroimaging findings in neurodevelopmental copy number variants: identifying molecular pathways to convergent phenotypes. Biol. Psychiatry https://doi.org/10.1016/j.biopsych.2022.03.018 (2022).
Chawner, S. J. R. A. et al. Genotype-phenotype associations in children with copy number variants associated with high neuropsychiatric risk in the UK (IMAGINE-ID): a case-control cohort study. Lancet Psychiatry 6, 493–505 (2019).
Marshall, C. R. et al. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat. Genet. 49, 27–35 (2017).
Sanders, S. J. et al. A framework for the investigation of rare genetic disorders in neuropsychiatry. Nat. Med. 25, 1477–1487 (2019).
Moreno-De-Luca, D. & Martin, C. L. All for one and one for all: heterogeneity of genetic etiologies in neurodevelopmental psychiatric disorders. Curr. Opin. Genet. Dev. 68, 71–78 (2021).
Crawford, K. et al. Medical consequences of pathogenic CNVs in adults: analysis of the UK Biobank. J. Med. Genet. 56, 131–138 (2019).
Owen, D. et al. Effects of pathogenic CNVs on physical traits in participants of the UK Biobank. BMC Genomics 19, 867 (2018).
Adams, R. L. et al. Psychopathology in adults with copy number variants. Psychol. Med. https://doi.org/10.1017/S0033291721005201 (2022).
Kendall, K. M. et al. Cognitive performance and functional outcomes of carriers of pathogenic copy number variants: analysis of the UK Biobank. Br. J. Psychiatry 214, 297–304 (2019).
Doelken, S. C. et al. Phenotypic overlap in the contribution of individual genes to CNV pathogenicity revealed by cross-species computational analysis of single-gene mutations in humans, mice and zebrafish. Dis. Model. Mech. 6, 358–372 (2013).
Viñas-Jornet, M. et al. High incidence of copy number variants in adults with intellectual disability and co-morbid psychiatric disorders. Behav. Genet. 48, 323–336 (2018).
Moreau, C. A. et al. Dissecting autism and schizophrenia through neuroimaging genomics. Brain 144, 1943–1957 (2021).
Moreau, C. A. et al. Mutations associated with neuropsychiatric conditions delineate functional brain connectivity dimensions contributing to autism and schizophrenia. Nat. Commun. 11, 5272 (2020).
Modenato, C. et al. Lessons learned from neuroimaging studies of copy number variants: a systematic review. Biol. Psychiatry 90, 596–610 (2021).
Sønderby, I. E. et al. Effects of copy number variations on brain structure and risk for psychiatric illness: large-scale studies from the ENIGMA working groups on CNVs. Hum. Brain Mapp. 43, 300–328 (2022).
Raznahan, A., Won, H., Glahn, D. C. & Jacquemont, S. Convergence and divergence of rare genetic disorders on brain phenotypes. JAMA Psychiatry 79, 818–828 (2022).
Zinkstok, J. R. et al. Neurobiological perspective of 22q11.2 deletion syndrome. Lancet Psychiatry 6, 951–960 (2019).
Bzdok, D., Nichols, T. E. & Smith, S. M. Towards algorithmic analytics for large-scale datasets. Nat. Mach. Intell. 1, 296–306 (2019).
Bzdok, D. & Yeo, B. T. T. Inference in the age of big data: future perspectives on neuroscience. Neuroimage 155, 549–564 (2017).
Littlejohns, T. J. et al. The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions. Nat. Commun. 11, 2624 (2020).
Weiss, L. A. et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358, 667–675 (2008).
Marek, S. et al. Reproducible brain-wide association studies require thousands of individuals. Nature 603, 654–660 (2022).
Gottesman, I. I. & Gould, T. D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 160, 636–645 (2003).
Mark, W. & Toulopoulou, T. Cognitive intermediate phenotype and genetic risk for psychosis. Curr. Opin. Neurobiol. 36, 23–30 (2016).
Meyer-Lindenberg, A. & Weinberger, D. R. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat. Rev. Neurosci. 7, 818–827 (2006).
Lin, A. et al. Mapping 22q11.2 gene dosage effects on brain morphometry. J. Neurosci. 37, 6183–6199 (2017).
Martin-Brevet, S. et al. Quantifying the effects of 16p11.2 copy number variants on brain structure: a multisite genetic-first study. Biol. Psychiatry 84, 253–264 (2018).
Sun, D. et al. Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: convergence with idiopathic psychosis and effects of deletion size. Mol. Psychiatry 25, 1822–1834 (2020).
Bracher-Smith, M. et al. Effects of pathogenic CNVs on biochemical markers: a study on the UK Biobank. Preprint at bioRxiv https://doi.org/10.1101/723270 (2019).
Miller, K. L. et al. Multimodal population brain imaging in the UK Biobank prospective epidemiological study. Nat. Neurosci. 19, 1523–1536 (2016).
Momma, K. Cardiovascular anomalies associated with chromosome 22q11.2 deletion syndrome. Am. J. Cardiol. 105, 1617–1624 (2010).
Pillinger, T., D’Ambrosio, E., McCutcheon, R. & Howes, O. D. Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models. Mol. Psychiatry 24, 776–794 (2019).
Van, L. et al. All-cause mortality and survival in adults with 22q11.2 deletion syndrome. Genet. Med. 21, 2328–2335 (2019).
Kessler, R. C. et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization’s World Mental Health Survey Initiative. World Psychiatry 6, 168–176 (2007).
Correll, C. U. et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry 16, 163–180 (2017).
Hoang, U., Goldacre, M. J. & Stewart, R. Avoidable mortality in people with schizophrenia or bipolar disorder in England. Acta Psychiatr. Scand. 127, 195–201 (2013).
Kirov, G. et al. The penetrance of copy number variations for schizophrenia and developmental delay. Biol. Psychiatry 75, 378–385 (2014).
Chawner, S. J., Watson, C. J. & Owen, M. J. Clinical evaluation of patients with a neuropsychiatric risk copy number variant. Curr. Opin. Genet. Dev. 68, 26–34 (2021).
Alessi, M. G. & Bennett, J. M. Mental health is the health of the whole body: how psychoneuroimmunology and health psychology can inform and improve treatment. J. Eval. Clin. Pract. 26, 1539–1547 (2020).
Guest, P. C. in Biomarkers and Mental Illness: It’s Not All in the Mind (ed. Guest, P. C.) 3–16 (Springer, 2017).
Kohane, I. S. et al. The co-morbidity burden of children and young adults with autism spectrum disorders. PLoS ONE 7, e33224 (2012).
Sotelo, J. L. & Nemeroff, C. B. Depression as a systemic disease. Pers. Med. Psychiatry 1–2, 11–25 (2017).
Leboyer, M. et al. Can bipolar disorder be viewed as a multi-system inflammatory disease? J. Affect. Disord. 141, 1–10 (2012).
Leppert, B. et al. A cross-disorder PRS-pheWAS of 5 major psychiatric disorders in UK Biobank. PLoS Genet. 16, e1008185 (2020).
Thompson, P. M. et al. Genetic influences on brain structure. Nat. Neurosci. 4, 1253–1258 (2001).
Bacchelli, E. et al. An integrated analysis of rare CNV and exome variation in Autism Spectrum Disorder using the Infinium PsychArray. Sci. Rep. 10, 3198 (2020).
Gratten, J. & Visscher, P. M. Genetic pleiotropy in complex traits and diseases: implications for genomic medicine. Genome Med. 8, 78 (2016).
Seidlitz, J. et al. Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disorders. Nat. Commun. 11, 3358 (2020).
Moreau, C. A., Ching, C. R., Kumar, K., Jacquemont, S. & Bearden, C. E. Structural and functional brain alterations revealed by neuroimaging in CNV carriers. Curr. Opin. Genet. Dev. 68, 88–98 (2021).
Rogdaki, M. et al. Magnitude and heterogeneity of brain structural abnormalities in 22q11.2 deletion syndrome: a meta-analysis. Mol. Psychiatry 25, 1704–1717 (2020).
Wysocki, A. C., Lawson, K. M. & Rhemtulla, M. Statistical control requires causal justification. Adv. Methods Pract. Psychol. Sci. https://doi.org/10.1177/25152459221095823 (2022).
Modenato, C. et al. Effects of eight neuropsychiatric copy number variants on human brain structure. Transl. Psychiatry 11, 399 (2021).
Ashburner, J. A fast diffeomorphic image registration algorithm. NeuroImage 38, 95–113 (2007).
Ashburner, J. & Friston, K. J. Unified segmentation. NeuroImage 26, 839–851 (2005).
Lorio, S. et al. New tissue priors for improved automated classification of subcortical brain structures on MRI. NeuroImage 130, 157–166 (2016).
Schaefer, A. et al. Local-global parcellation of the human cerebral cortex from intrinsic functional connectivity MRI. Cereb. Cortex 28, 3095–3114 (2018).
Alfaro-Almagro, F. et al. Image processing and quality control for the first 10,000 brain imaging datasets from UK Biobank. NeuroImage 166, 400–424 (2018).
Smith, S. M. Fast robust automated brain extraction. Hum. Brain Mapp. 17, 143–155 (2002).
Jenkinson, M., Bannister, P., Brady, M. & Smith, S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage 17, 825–841 (2002).
Andersson, J. L., Jenkinson, M. & Smith, S. Non-linear Registration aka Spatial Normalisation FMRIB Technical Report TR07JA2 (FMRIB Analyis Group Univ. Oxford, 2007).
Zhang, Y., Brady, M. & Smith, S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans. Med. Imaging 20, 45–57 (2001).
Schurz, M. et al. Variability in brain structure and function reflects lack of peer support. Cereb. Cortex 31, 4612–4627 (2021).
Spreng, R. N. et al. The default network of the human brain is associated with perceived social isolation. Nat. Commun. 11, 6393 (2020).
Alexander-Bloch, A., Giedd, J. N. & Bullmore, E. Imaging structural co-variance between human brain regions. Nat. Rev. Neurosci. 14, 322–336 (2013).
Savignac, C. et al. APOE ɛ2 vs APOE ɛ4 dosage shows sex-specific links to hippocampus-default network subregion co-variation. PLOS Biology 20, e3001863 (2022).
Millard, L. A. C., Davies, N. M., Gaunt, T. R., Davey Smith, G. & Tilling, K. Software application profile: PHESANT: a tool for performing automated phenome scans in UK Biobank. Int. J. Epidemiol. 47, 29–35 (2018).
Hastie, T., Tibshirani, R. & Friedman, J. The Elements of Statistical Learning: Data Mining, Inference, and Prediction 2nd edn (Springer, 2009).
Bzdok, D. & Ioannidis, J. P. A. Exploration, inference, and prediction in neuroscience and biomedicine. Trends Neurosci. 42, 251–262 (2019).
Duda, R. O., Hart, P. E. & Stork, D. G. Pattern Classification (Wiley, 2000).
Breiman, L. Bagging predictors. Mach. Learn. 24, 123–140 (1996).
Chicco, D. & Jurman, G. The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation. BMC Genomics 21, 6 (2020).
Efron, B. & Tibshirani, R. J. An Introduction to the Bootstrap (CRC Press, 1994).
Fry, A. et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am. J. Epidemiol. 186, 1026–1034 (2017).
Acknowledgements
D.B. was supported by the Brain Canada Foundation, through the Canada Brain Research Fund, with the financial support of Health Canada, the National Institutes of Health (NIH R01 AG068563A, NIH R01 R01DA053301-01A1), the Canadian Institute of Health Research (CIHR 438531, CIHR 470425), the Healthy Brains Healthy Lives initiative (Canada First Research Excellence fund), Google (Research Award, Teaching Award) and by the CIFAR Artificial Intelligence Chairs programme (Canada Institute for Advanced Research). This research was supported by Calcul Quebec (http://www.calculquebec.ca) and Compute Canada (http://www.computecanada.ca), the Brain Canada Multi-Investigator initiative, the Canadian Institutes of Health Research, CIHR_400528, the Institute of Data Valorization (IVADO) through the Canada First Research Excellence Fund, Healthy Brains for Healthy Lives through the Canada First Research Excellence Fund. S.J. is a recipient of a Canada Research Chair in neurodevelopmental disorders and a chair from the Jeanne et Jean Louis Levesque Foundation. The Cardiff CNV cohort was supported by the Wellcome Trust Strategic Award ‘DEFINE’ and the National Centre for Mental Health with funds from Health and Care Research Wales (code 100202/Z/12/Z). The CHUV cohort was supported by the SNF (Maillard Anne, Project PMPDP3 171331). Data from the UCLA cohort provided by C.E.B. (participants with 22q11.2 deletions or duplications and controls) were supported through grants from the NIH (U54EB020403), NIMH (R01MH085953, R01MH100900, R03MH105808) and the Simons Foundation (SFARI Explorer Award). K.K. was supported by the Institute of Data Valorization (IVADO) Postdoctoral Fellowship programme through the Canada First Research Excellence Fund. I.E.S. was supported by the Research Council of Norway (No. 223273), South-Eastern Norway Regional Health Authority (No. 2020060), European Union’s Horizon2020 Research and Innovation Programme (CoMorMent project; Grant No. 847776) and Kristian Gerhard Jebsen Stiftelsen (SKGJ-MED-021). We thank all of the families participating at the Simons Searchlight sites and the 16p11.2 European Consortium, Simons Searchlight Consortium. We appreciate obtaining access to brain-imaging and phenotypic data on SFARI Base. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the paper.
Author information
Authors and Affiliations
Contributions
J.K., D.B. and S.J. designed the study, analysed imaging data and drafted the paper. J.K., C.M. and K.K. did all the preprocessing and analysis of neuroimaging data. K.S. provided scripts for the PheWAS analysis. D.B. and S.J. contributed to the interpretation of the results and the editing of the paper. C.M., A.M.M., A.P., S.R. and S.M.-B. recruited and scanned participants in the 16p11.2 European Consortium. S.L., C.-O.M., N.Y., P.T. and E.D. recruited and scanned participants in the Brain Canada cohort. L.K. collected and provided the data for the UCLA cohort. D.E.J.L., M.J.O., M.B.M.v.d.B., J.H. and A.I.S. provided the data for the Cardiff cohort. All authors provided feedback on the paper. D.B. led data analytics.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Human Behaviour thanks Toru Takumi, Serafeim Loukas and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
Supplementary Figs. 1–14 and consortia members.
Source data
Source Data Fig. 1
Cohen’s d brain maps and their similarity, and PC and LDA embedding of CNV carriers.
Source Data Fig. 2
Performance of LDA models, LDA coefficients and their similarity.
Source Data Fig. 3
Significant LDA coefficients and their association with Cohen’s d, sample size, classification accuracy and CNV attributes.
Source Data Fig. 4
LDA expression in clinical dataset and UK Biobank, PheWAS analysis and percentages of associated phenotypes.
Source Data Fig. 5
PheWAS analyses and their similarities.
Source Data Fig. 6
Most commonly and strongly associated phenotypes, additional PheWAS analysis, and comparison of volumetric and phenotypic similarity.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kopal, J., Kumar, K., Saltoun, K. et al. Rare CNVs and phenome-wide profiling highlight brain structural divergence and phenotypical convergence. Nat Hum Behav 7, 1001–1017 (2023). https://doi.org/10.1038/s41562-023-01541-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41562-023-01541-9
This article is cited by
-
Rare copy-number variants as modulators of common disease susceptibility
Genome Medicine (2024)
-
Genetic and phenotypic similarity across major psychiatric disorders: a systematic review and quantitative assessment
Translational Psychiatry (2024)
-
Using rare genetic mutations to revisit structural brain asymmetry
Nature Communications (2024)